Sonic Healthcare Limited

Equities

SHL

AU000000SHL7

Healthcare Facilities & Services

Market Closed - Australian S.E. 02:10:52 2024-04-24 am EDT 5-day change 1st Jan Change
26.74 AUD -0.41% Intraday chart for Sonic Healthcare Limited +2.89% -16.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Microba's Revenue Climbs 297% in Fiscal Q3 MT
Sonic Healthcare Limited agreed to acquire Dr. Risch Shared Services Ag for CHF 117 million. CI
Sonic Healthcare Signs Binding Agreement to Acquire Swiss Medical Lab Group Dr Risch MT
Sonic Healthcare to Pay $132 Million for Swiss Lab Group DJ
Proteomics Says PromarkerD's US Launch Delayed MT
Sonic Healthcare Subsidiary Signs NHS Pathology Contract in UK MT
Sonic Healthcare's UK Subsidiary Signs Pathology Services Contract with NHS MT
Microba Life Sciences Rise 9% Following Launch of MetaPanel Test With Sonic Healthcare MT
Morgan Stanley Adjusts Sonic Healthcare’s Price Target to AU$33.60 From AU$35.55, Keeps at Overweight MT
Australian shares skid off record highs to end lower; GDP data awaited RE
Jarden Research Adjusts Sonic Healthcare’s Price Target to AU$28.88 From AU$31.20, Keeps at Neutral MT
Sonic Healthcare Shares Fall 6% as Profit Slips, Revenue Rises 5.5% in H1 FY24 MT
Transcript : Sonic Healthcare Limited, H1 2024 Earnings Call, Feb 20, 2024
Sonic Healthcare 1st Half Net Profit Falls 47% DJ
Sonic Healthcare Posts 5.5% Rise in H1 FY24 Revenue, Profit Slips MT
Sonic Healthcare Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Sonic Healthcare Limited completed the acquisition of Pathology Watch Inc. for $150 million. CI
Sonic Healthcare Acquiring Pathology Watch for $130 Million; Shares Down 5% MT
Transcript : Sonic Healthcare Limited - Shareholder/Analyst Call
Sonic Healthcare Agrees US$150 Million Acquisition of Pathology Watch DJ
Australian shares rise on gold, healthcare boost; RBA meeting in focus RE
Microba Life Sciences' Domestica, International Personal Testing Revenue Rises in Fiscal Q1 MT
Australia's CSL tanks as Novo Nordisk's kidney trial success stokes competition concerns RE
Sonic Healthcare Limited completed the acquisition of Diagnosticum Gmbh. CI
Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023 CI
Chart Sonic Healthcare Limited
More charts
Sonic Healthcare Limited is an Australia-based healthcare provider. The Company is engaged in specialist operations in laboratory medicine / pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America. Its segments include Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. Sonic Clinical Services (SCS) is the primary care division of the Company, which provides a range of health services. The Company's services are provided to medical practitioners, hospitals, community health services, and their collective patients. The Company has more than 120 radiology centers.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
26.74 AUD
Average target price
30.69 AUD
Spread / Average Target
+14.79%
Consensus
  1. Stock Market
  2. Equities
  3. SHL Stock
  4. News Sonic Healthcare Limited
  5. Sonic Healthcare : Fiscal H1 Net Profit Surges 166% on Strong European, US Business